Skip to main content
Erschienen in: European Radiology 8/2022

03.03.2022 | Imaging Informatics and Artificial Intelligence

Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer

verfasst von: Haoxin Zheng, Qi Miao, Yongkai Liu, Sohrab Afshari Mirak, Melina Hosseiny, Fabien Scalzo, Steven S. Raman, Kyunghyun Sung

Erschienen in: European Radiology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To identify which patient with prostate cancer (PCa) could safely avoid extended pelvic lymph node dissection (ePLND) by predicting lymph node invasion (LNI), via a radiomics-based machine learning approach.

Methods

An integrative radiomics model (IRM) was proposed to predict LNI, confirmed by the histopathologic examination, integrating radiomics features, extracted from prostatic index lesion regions on MRI images, and clinical features via SVM. The study cohort comprised 244 PCa patients with MRI and followed by radical prostatectomy (RP) and ePLND within 6 months between 2010 and 2019. The proposed IRM was trained in training/validation set and evaluated in an internal independent testing set. The model’s performance was measured by area under the curve (AUC), sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). AUCs were compared via Delong test with 95% confidence interval (CI), and the rest measurements were compared via chi-squared test or Fisher’s exact test.

Results

Overall, 17 (10.6%) and 14 (16.7%) patients with LNI were included in training/validation set and testing set, respectively. Shape and first-order radiomics features showed usefulness in building the IRM. The proposed IRM achieved an AUC of 0.915 (95% CI: 0.846–0.984) in the testing set, superior to pre-existing nomograms whose AUCs were from 0.698 to 0.724 (p < 0.05).

Conclusion

The proposed IRM could be potentially feasible to predict the risk of having LNI for patients with PCa. With the improved predictability, it could be utilized to assess which patients with PCa could safely avoid ePLND, thus reduce the number of unnecessary ePLND.

Key Points

The combination of MRI-based radiomics features with clinical information improved the prediction of lymph node invasion, compared with the model using only radiomics features or clinical features.
With improved prediction performance on predicting lymph node invasion, the number of extended pelvic lymph node dissection (ePLND) could be reduced by the proposed integrative radiomics model (IRM), compared with the existing nomograms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wilczak W, Wittmer C, Clauditz T et al (2018) Marked prognostic impact of minimal lymphatic tumor spread in prostate cancer. Eur Urol 74:376–386CrossRefPubMed Wilczak W, Wittmer C, Clauditz T et al (2018) Marked prognostic impact of minimal lymphatic tumor spread in prostate cancer. Eur Urol 74:376–386CrossRefPubMed
2.
Zurück zum Zitat Chen J, Wang Z, Zhao J et al (2019) Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database. Sci Rep 9:17985CrossRefPubMed Chen J, Wang Z, Zhao J et al (2019) Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database. Sci Rep 9:17985CrossRefPubMed
3.
Zurück zum Zitat Fossati N, Willemse PM, Van den Broeck T et al (2017) The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 72:84–109CrossRefPubMed Fossati N, Willemse PM, Van den Broeck T et al (2017) The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 72:84–109CrossRefPubMed
4.
Zurück zum Zitat Mottet N, Bellmunt J, Briers S et al (2021) EAU Guidelines EAU Annual Congress, Milan Mottet N, Bellmunt J, Briers S et al (2021) EAU Guidelines EAU Annual Congress, Milan
6.
Zurück zum Zitat Yu JB, Makarov DV, Gross C (2011) A new formula for prostate cancer lymph node risk. Int J Radiat Oncol Biol Phys 80:69–75CrossRefPubMed Yu JB, Makarov DV, Gross C (2011) A new formula for prostate cancer lymph node risk. Int J Radiat Oncol Biol Phys 80:69–75CrossRefPubMed
7.
Zurück zum Zitat Venclovas Z, Muilwijk T, Matjosaitis AJ, Jievaltas M, Joniau S, Milonas D (2021) Head-to-head comparison of two nomograms predicting probability of lymph node invasion in prostate cancer and the therapeutic impact of higher nomogram threshold. J Clin Med 10:999CrossRefPubMed Venclovas Z, Muilwijk T, Matjosaitis AJ, Jievaltas M, Joniau S, Milonas D (2021) Head-to-head comparison of two nomograms predicting probability of lymph node invasion in prostate cancer and the therapeutic impact of higher nomogram threshold. J Clin Med 10:999CrossRefPubMed
8.
Zurück zum Zitat Soeterik TFW, Hueting TA, Israel B et al (2021) External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging. BJU Int. 128:236–243CrossRefPubMed Soeterik TFW, Hueting TA, Israel B et al (2021) External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging. BJU Int. 128:236–243CrossRefPubMed
9.
Zurück zum Zitat Roach M, Marquez C, Yuo H-S et al (1993) Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 28:33–37CrossRef Roach M, Marquez C, Yuo H-S et al (1993) Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 28:33–37CrossRef
11.
Zurück zum Zitat Briganti A, Larcher A, Abdollah F et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480–487CrossRefPubMed Briganti A, Larcher A, Abdollah F et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480–487CrossRefPubMed
12.
Zurück zum Zitat Sprute K, Kramer V, Koerber SA et al (2021) Diagnostic accuracy of (18) F-PSMA-1007 PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence. J Nucl Med 62:208–213CrossRefPubMed Sprute K, Kramer V, Koerber SA et al (2021) Diagnostic accuracy of (18) F-PSMA-1007 PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence. J Nucl Med 62:208–213CrossRefPubMed
13.
Zurück zum Zitat Cysouw MCF, Jansen BHE, van de Brug T et al (2021) Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging 48:340–349CrossRefPubMed Cysouw MCF, Jansen BHE, van de Brug T et al (2021) Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging 48:340–349CrossRefPubMed
14.
Zurück zum Zitat Zamboglou C, Carles M, Fechter T et al (2019) Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference. Theranostics 9:2595–2605CrossRefPubMed Zamboglou C, Carles M, Fechter T et al (2019) Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference. Theranostics 9:2595–2605CrossRefPubMed
15.
Zurück zum Zitat Barbosa FG, Queiroz MA, Nunes RF, Marin JFG, Buchpiguel CA, Cerri GG (2018) Clinical perspectives of PSMA PET/MRI for prostate cancer. Clinics (Sao Paulo) 73:e586sCrossRef Barbosa FG, Queiroz MA, Nunes RF, Marin JFG, Buchpiguel CA, Cerri GG (2018) Clinical perspectives of PSMA PET/MRI for prostate cancer. Clinics (Sao Paulo) 73:e586sCrossRef
16.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging - reporting and data system: 2015, Version 2. European Urology 69:16–40CrossRefPubMed Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging - reporting and data system: 2015, Version 2. European Urology 69:16–40CrossRefPubMed
17.
Zurück zum Zitat Huang C, Song G, Wang H et al (2020) Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Prostate Cancer Prostatic Dis 23:116–126CrossRefPubMed Huang C, Song G, Wang H et al (2020) Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Prostate Cancer Prostatic Dis 23:116–126CrossRefPubMed
18.
Zurück zum Zitat Hatano K, Tanaka J, Nakai Y et al (2020) Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer. Jpn J Clin Oncol 50:333–337CrossRefPubMed Hatano K, Tanaka J, Nakai Y et al (2020) Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer. Jpn J Clin Oncol 50:333–337CrossRefPubMed
19.
Zurück zum Zitat Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRefPubMed Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRefPubMed
20.
Zurück zum Zitat Tomaszewski MR, Gillies RJ (2021) The biological meaning of radiomic features. Radiology 298:505–516CrossRefPubMed Tomaszewski MR, Gillies RJ (2021) The biological meaning of radiomic features. Radiology 298:505–516CrossRefPubMed
21.
Zurück zum Zitat Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338CrossRefPubMed Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338CrossRefPubMed
22.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology Vol. 278, No.2 Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology Vol. 278, No.2
23.
Zurück zum Zitat Cuocolo R, Stanzione A, Faletti R et al (2021) MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study. Eur Radiol. 31:7575–7583CrossRefPubMed Cuocolo R, Stanzione A, Faletti R et al (2021) MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study. Eur Radiol. 31:7575–7583CrossRefPubMed
24.
Zurück zum Zitat Gugliandolo SG, Pepa M, Isaksson LJ et al (2021) MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218). Eur Radiol 31:716–728CrossRefPubMed Gugliandolo SG, Pepa M, Isaksson LJ et al (2021) MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218). Eur Radiol 31:716–728CrossRefPubMed
25.
Zurück zum Zitat Hectors SJ, Cherny M, Yadav KK et al (2019) Radiomics features measured with multiparametric magnetic resonance imaging predict prostate cancer aggressiveness. J Urol 202:498–505CrossRefPubMed Hectors SJ, Cherny M, Yadav KK et al (2019) Radiomics features measured with multiparametric magnetic resonance imaging predict prostate cancer aggressiveness. J Urol 202:498–505CrossRefPubMed
26.
Zurück zum Zitat Yan C, Peng Y, Li X (2019) Radiomics analysis for prostate cancer classification in multiparametric magnetic resonance imagesInternational Conference on Biological Information and Biomedical Engineering. IEEE, Hangzhou, China, 247-250 Yan C, Peng Y, Li X (2019) Radiomics analysis for prostate cancer classification in multiparametric magnetic resonance imagesInternational Conference on Biological Information and Biomedical Engineering. IEEE, Hangzhou, China, 247-250
27.
Zurück zum Zitat Zhang GM, Han YQ, Wei JW et al (2020) Radiomics based on MRI as a biomarker to guide therapy by predicting upgrading of prostate cancer from biopsy to radical prostatectomy. J Magn Reson Imaging 52:1239–1248CrossRefPubMed Zhang GM, Han YQ, Wei JW et al (2020) Radiomics based on MRI as a biomarker to guide therapy by predicting upgrading of prostate cancer from biopsy to radical prostatectomy. J Magn Reson Imaging 52:1239–1248CrossRefPubMed
28.
Zurück zum Zitat Li M, Zhang J, Dan Y et al (2020) A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer. J Transl Med 18:46CrossRefPubMed Li M, Zhang J, Dan Y et al (2020) A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer. J Transl Med 18:46CrossRefPubMed
29.
Zurück zum Zitat Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed
30.
Zurück zum Zitat Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340–351CrossRefPubMed Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340–351CrossRefPubMed
31.
Zurück zum Zitat Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRefPubMed Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRefPubMed
32.
Zurück zum Zitat Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Selection bias and information bias in clinical research. Nephron Clin Pract 115:94–99CrossRef Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Selection bias and information bias in clinical research. Nephron Clin Pract 115:94–99CrossRef
34.
Zurück zum Zitat Cao R, Mohammadian Bajgiran A, Afshari Mirak S et al (2019) Joint prostate cancer detection and Gleason score prediction in mp-MRI via FocalNet. IEEE Trans Med Imaging 38:2496–2506CrossRefPubMed Cao R, Mohammadian Bajgiran A, Afshari Mirak S et al (2019) Joint prostate cancer detection and Gleason score prediction in mp-MRI via FocalNet. IEEE Trans Med Imaging 38:2496–2506CrossRefPubMed
35.
Zurück zum Zitat Tustison NJ, Avants BB, Cook PA et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320CrossRefPubMed Tustison NJ, Avants BB, Cook PA et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310–1320CrossRefPubMed
36.
Zurück zum Zitat van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:104–107CrossRef van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:104–107CrossRef
37.
Zurück zum Zitat Zongker D, Jain A (1996) Algorithms for features selection: an evaluationinternational conference on pattern recognition. IEEE, Vienna, Austria, Austria Zongker D, Jain A (1996) Algorithms for features selection: an evaluationinternational conference on pattern recognition. IEEE, Vienna, Austria, Austria
38.
Zurück zum Zitat DeLong ER, Delong DM, Clarke-Pearon DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, Delong DM, Clarke-Pearon DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
39.
Zurück zum Zitat Gnep K, Fargeas A, Gutierrez-Carvajal RE et al (2017) Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45:103–117CrossRefPubMed Gnep K, Fargeas A, Gutierrez-Carvajal RE et al (2017) Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging 45:103–117CrossRefPubMed
40.
Zurück zum Zitat Morris KA, Haboubi NY (2015) Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg 7:279–288CrossRefPubMed Morris KA, Haboubi NY (2015) Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg 7:279–288CrossRefPubMed
41.
Zurück zum Zitat Meerleer GD, Berghen C, Briganti A et al (2021) Elective nodal radiotherapy in prostate cancer. Lancet Oncol 22:348–357 Meerleer GD, Berghen C, Briganti A et al (2021) Elective nodal radiotherapy in prostate cancer. Lancet Oncol 22:348–357
42.
Zurück zum Zitat Liechti MR, Muehlematter UJ, Schneider AF et al (2020) Manual prostate cancer segmentation in MRI: interreader agreement and volumetric correlation with transperineal template core needle biopsy. Eur Radiol 30:4806–4815CrossRefPubMed Liechti MR, Muehlematter UJ, Schneider AF et al (2020) Manual prostate cancer segmentation in MRI: interreader agreement and volumetric correlation with transperineal template core needle biopsy. Eur Radiol 30:4806–4815CrossRefPubMed
43.
Zurück zum Zitat Fleiss JL (1981) Statistical Methods for Rates and Proportions, 2nd Edition Fleiss JL (1981) Statistical Methods for Rates and Proportions, 2nd Edition
Metadaten
Titel
Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer
verfasst von
Haoxin Zheng
Qi Miao
Yongkai Liu
Sohrab Afshari Mirak
Melina Hosseiny
Fabien Scalzo
Steven S. Raman
Kyunghyun Sung
Publikationsdatum
03.03.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08625-6

Weitere Artikel der Ausgabe 8/2022

European Radiology 8/2022 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.